Efficacy and Safety of IV albumin for non-spontaneous bacterial peritonitis infection among patients with cirrhosis: A systematic review and meta-analysis-Reference-Cited by-同舟云学术

Efficacy and Safety of IV albumin for non-spontaneous bacterial peritonitis infection among patients with cirrhosis: A systematic review and meta-analysis

Published:2020-10 Issue:10 Volume:52 Page:1137-1142
ISSN:1590-8658
Container-title:Digestive and Liver Disease
language:en
Short-container-title:Digestive and Liver Disease

Author:

WONG Yu-Jun,QIU Tian-Yu,TAM Yew-Chong,MOHAN Babu P,GALLEGOS-OROZCO Juan-F,ADLER Douglas G

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference20 articles.

1. Infection in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis;Arvaniti;Gastroenterology,2010

2. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis;Moreau;Gastroenterology,2013

3. Bacterial infection in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis;Fernandez;Hepatology,2002

4. Renal failure in patients with cirrhosis and sepsis unrelated to spontaneous bacterial peritonitis: value of MELD score;Terra;Gastroenterology,2005

5. Randomized trial comparing albumin, dextran 70, and polygeline in cirrhotic patients with ascites treated by paracentesis;Gines;Gastroenterology,1996

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Use of Intravenous Albumin;CHEST;2024-08

2. AGA Clinical Practice Update on the Use of Vasoactive Drugs and Intravenous Albumin in Cirrhosis: Expert Review;Gastroenterology;2024-01

3. A Study of Impact of Fixed-Dose Albumin Infusion on Outcome in Patients With Cirrhosis and Infection: A Randomized Open-label Clinical Trial;Journal of Clinical and Experimental Hepatology;2024-01

4. Consensus document on acute-on-chronic liver failure (ACLF) established by the Mexican Association of Hepatology;Annals of Hepatology;2023-11

5. Controversies regarding albumin therapy in cirrhosis;Hepatology;2023-08-07